Evrofarma SA (ATH:EVROF)

Evrofarma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 1, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	47	25	16	10	12	13
Market Cap Growth	86.92%	50.83%	68.54%	-21.76%	-4.61%	-18.11%
Enterprise Value	58	41	37	32	32	31
Last Close Price	3.43	1.78	1.14	0.68	0.87	0.91
PE Ratio	21.45	10.86	7.45	6.86	-	12.32
PS Ratio	1.03	0.54	0.34	0.22	0.34	0.39
PB Ratio	2.63	1.39	1.01	0.69	0.99	1.01
P/TBV Ratio	2.65	1.40	1.01	0.70	1.00	1.02
P/FCF Ratio	11.36	6.00	30.73	16.23	-	23.55
P/OCF Ratio	8.76	4.62	5.22	3.69	-	8.95
EV/Sales Ratio	1.24	0.91	0.77	0.71	0.87	0.92
EV/EBITDA Ratio	10.60	7.08	7.04	8.59	19.49	11.10
EV/EBIT Ratio	15.50	10.15	10.22	14.28	137.87	21.18
EV/FCF Ratio	14.08	10.04	69.98	53.69	-	56.44
Debt / Equity Ratio	0.95	0.95	1.20	1.52	1.69	1.64
Debt / EBITDA Ratio	2.87	2.87	3.64	5.63	12.75	7.39
Debt / FCF Ratio	4.11	4.11	36.57	35.63	-	38.30
Net Debt / Equity Ratio	0.77	0.77	1.16	1.42	1.67	1.40
Net Debt / EBITDA Ratio	2.33	2.33	3.55	5.32	12.89	6.43
Net Debt / FCF Ratio	3.30	3.30	35.34	33.24	-5.07	32.69
Asset Turnover	0.96	0.96	1.01	0.95	0.79	0.77
Inventory Turnover	5.36	5.36	6.91	9.17	9.89	8.70
Quick Ratio	0.59	0.59	0.75	1.04	1.37	1.43
Current Ratio	0.98	0.98	1.25	1.48	1.67	1.76
Return on Equity (ROE)	13.39%	13.39%	14.56%	10.66%	-2.78%	8.53%
Return on Assets (ROA)	5.33%	5.33%	4.75%	2.96%	0.31%	2.11%
Return on Invested Capital (ROIC)	10.24%	9.68%	8.61%	6.22%	0.71%	4.33%
Return on Capital Employed (ROCE)	13.60%	13.60%	10.70%	6.20%	0.60%	4.10%
Earnings Yield	4.86%	9.21%	13.42%	14.58%	-2.85%	8.12%
FCF Yield	8.80%	16.68%	3.26%	6.16%	-33.37%	4.25%
Dividend Yield	1.50%	-	4.38%	-	-	-
Payout Ratio	29.82%	29.83%	-	-	-	-
Buyback Yield / Dilution	-	-	-0.05%	0.02%	-	-
Total Shareholder Return	1.50%	-	4.33%	0.02%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.